DM Maahs, LG Ogden, A Kretowski, JK Snell- … - Diabetes, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Coronary artery calcification was measured twice,
using Imatron C-150 Ultrafast CT, over a 2.5 ± 0.4-year interval in 509 adults
with type 1 diabetes (42% male, age 36 ± 9 years, duration 23 ± 9 years). ... Cited by 8 - Related articles - BL Direct - All 5 versions
SH Song, IS Kwak, YJ Kim, HS Lee, H Rhee, … - Hypertension Research, 2008 - nature.com We hypothesized that serum cystatin C can be a more predictable marker of
arterial stiffness than serum creatinine and creatinine-based glomerular
filtration rate (GFR). The aim of this study is to evaluate whether serum ... Cited by 1 - Related articles - All 3 versions
NI Parikh, SJ Hwang, Q Yang, MG Larson, CY … - The American Journal of Cardiology, 2008 - Elsevier Cystatin C (CysC) is associated with cardiovascular disease (CVD) and chronic
kidney disease (CKD). We examined the clinical correlates and heritability of
CysC and determined if associations between CVD risk factors and CysC ... Cited by 4 - Related articles - All 2 versions
A Servais, P Giral, M Bernard, E Bruckert, G … - The American Journal of Medicine, 2008 - Elsevier PURPOSE: Chronic kidney disease and metabolic syndrome are recognized as major
cardiovascular risk factors. It has been shown that cystatin C has a stronger
association with mortality risk than creatinine-based estimations of ... Cited by 14 - Related articles - All 19 versions
RP Donahue, S Stranges, K Rejman, LB … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— In 2002–2004, 1,455 participants from the
Western New York Health Study, who were free of type 2 diabetes and known
cardiovascular disease at baseline (1996–2001), were reexamined. An ... Cited by 15 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org L Ni, J Lu, L Bo Hou, J Tao Yan, Q Fan, R … - Stroke, 2007 - Am Heart Assoc Background and Purpose— Cystatin C, a serum measure of renal function, has
been reported as a strong predictor of risk of death and cardiovascular events
in elderly people. We investigated the association between cystatin C and ... Cited by 7 - Related articles - All 4 versions
P Muntner, D Mann, J Winston, S Bansilal, … - The American Journal of Cardiology, 2008 - Elsevier Previous studies indicated that serum cystatin C, a marker of renal function,
was associated with cardiovascular disease (CVD). However, few data about this
association are available for persons without chronic kidney disease or ... Cited by 8 - Related articles - All 19 versions
TM Brown, V Bittner - Current Cardiovascular Risk Reports, 2009 - Springer Introduction Traditionally, risk prediction models incorporate demo- graphic and
clinical variables such as age, gender, blood pressure, cholesterol levels,
diabetes status, and smoking status to risk stratify individuals with known ... Related articles - All 3 versions
SH Lee, SA Park, SH Ko, HW Yim, YB Ahn, … - Metabolism: clinical and experimental, 2009 - ncbi.nlm.nih.gov Recent studies suggest that serum cystatin C level is not only a sensitive
marker for renal dysfunction but also a predictive marker for cardiovascular
disease (CVD). However, the mechanism of this connection is not fully ... Related articles - All 2 versions
오기원 - 210.101.116.17 Cystatin C는 122 아미노산과 13 kD의 작은 단백질로서 시스테인
단백분해효소의 억제제이다1). Cystatin C는 세포 외
단백질분해 제어, 면역계 조절, 항균 및 항바이러스 ... Related articles - View as HTML - All 4 versions
